Immutep Ltd (NASDAQ:IMMP)

1.79
Delayed Data
As of Feb 16
 -0.0361 / -1.98%
Today’s Change
1.25
Today|||52-Week Range
3.24
+13.94%
Year-to-Date
No recent news for Immutep Ltd.

Today’s Trading

Previous close1.83
Today’s open1.80
Day’s range1.77 - 1.80
Volume10,706
Average volume (3 months)78,572
Market cap$42.2M
Data as of 2:49pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+83.16%
Earnings growth (this year)+94.35%
Earnings growth (next 5 years)+0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
AEZSAEterna Zentaris Inc-0.05-2.56%
PRTOProteon Therapeutics...-0.02-1.18%
FSIFlexible Solutions I...-0.05-3.01%
HTGMHTG Molecular Diagno...+0.01+0.20%
Data as of 4:00pm ET, 02/16/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$7.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Marc Voigt
COO, Secretary &
General Counsel
Deanne Miller
Corporate headquarters
Sydney, New South Wales (nsw)

Forecasts